PLXDC1
Plexin domain-containing protein 1
Also known as: PLDX1_HUMAN, TEM3, TEM7
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IUK5
- Gene
- PLXDC1
- Ensembl
- ENSG00000161381
- Chromosome
- 17
- Canonical length
- 500 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
Predicted to be involved in angiogenesis. Part of receptor complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
500 residues, UniProt reviewed canonical sequence.
>Q8IUK5|PLXDC1
1 MRGELWLLVL VLREAARALS PQPGAGHDEG PGSGWAAKGT VRGWNRRARE SPGHVSEPDR
61 TQLSQDLGGG TLAMDTLPDN RTRVVEDNHS YYVSRLYGPS EPHSRELWVD VAEANRSQVK
121 IHTILSNTHR QASRVVLSFD FPFYGHPLRQ ITIATGGFIF MGDVIHRMLT ATQYVAPLMA
181 NFNPGYSDNS TVVYFDNGTV FVVQWDHVYL QGWEDKGSFT FQAALHHDGR IVFAYKEIPM
241 SVPEISSSQH PVKTGLSDAF MILNPSPDVP ESRRRSIFEY HRIELDPSKV TSMSAVEFTP
301 LPTCLQHRSC DACMSSDLTF NCSWCHVLQR CSSGFDRYRQ EWMDYGCAQE AEGRMCEDFQ
361 DEDHDSASPD TSFSPYDGDL TTTSSSLFID SLTTEDDTKL NPYAGGDGLQ NNLSPKTKGT
421 PVHLGTIVGI VLAVLLVAAI ILAGIYINGH PTSNAALFFI ERRPHHWPAM KFRSHPDHST
481 YAEVEPSGHE KEGFMEAEQCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PLXDC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 45 nTPM
Expression across tissuesHPA
Tissue
- retina: 45 nTPM
- heart muscle: 22 nTPM
- thymus: 22 nTPM
- tongue: 17 nTPM
- ovary: 14 nTPM
- gallbladder: 13 nTPM
Single-cell type
- retinal bipolar cells: 489 nCPM
- fibro-adipogenic progenitors: 105 nCPM
- retinal amacrine cells: 97 nCPM
- retinal ganglion cells: 85 nCPM
- pericytes: 84 nCPM
- myosatellite cells: 51 nCPM
Immune cell
- naive CD8 T-cell: 2.3 nTPM
- naive CD4 T-cell: 2.1 nTPM
- gdT-cell: 1.8 nTPM
- MAIT T-cell: 1.5 nTPM
- NK-cell: 1.1 nTPM
- plasmacytoid DC: 0.9 nTPM
Brain region
- cerebral cortex: 20 nTPM
- midbrain: 18 nTPM
- cerebellum: 17 nTPM
- thalamus: 14 nTPM
- pons: 13 nTPM
- white matter: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.91
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.02
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PLXDC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PLXDC1 as an antibody target. Whether an autoantibody or antibody against PLXDC1 could matter depends on whether native PLXDC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PLXDC1 is annotated at the cell surface, where native PLXDC1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PLXDC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...